Manufacturer record
Ozone Pharmaceuticals Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Ozone Pharmaceuticals Ltd (Himachal Pradesh) were declared Not of Standard Quality between February 2022 and December 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: A21410, AXBEX Suspension (Multivitamin Mulltimineral & Antioxidant Suspension) (exp Oct 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: Identification & Assay of Cholecalciferol. Listed in the December 2024 alert.
Records by type
4 records linked to Ozone Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| AXBEX Suspension (Multivitamin Mulltimineral & Antioxidant Suspension) | Batch A21410Mfg May 2024 · Exp Oct 2025 | Identification & Assay of CholecalciferolAssay | CDL KolkataCDSCO lab | Dec 2024 |
| AXBEX Suspension (Multivitamin Mulltimineral & Antioxidant Suspension) | Batch A21411Mfg May 2024 · Exp Oct 2025 | Identification & Assay of CholecalciferolAssay | CDL KolkataCDSCO lab | Dec 2024 |
| Glimepride, Pioglitazone Hydrochloride & Metformin Hydrochloride (Extended Release) Tablets (OZOMET-PG 2) | Batch BE32456Mfg May 2024 · Exp Apr 2026 | Assay of PioglitazoneAssay | CDL KolkataCDSCO lab | Nov 2024 |
| Atorvastatin Tablets IP (OZOVAS-10 TABLETS) | Batch BE9047Mfg Mar 2021 · Exp Feb 2023 | DissolutionDissolution | RDTL ChandigarhState lab | Feb 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.